MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjögren’s syndrome

References

• Tzioufas AG, Kapsogeorgou EK, Moutsopoulos HM. Pathogenesis of sjogren’s syndrome: what we know and what we should learn. J Autoimmun. 2012;39:4–8.
   PubMed Web of Science ®Google Scholar
• Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of sjogren’s syndrome. Nat Rev Rheumatol. 2010;6:529–537.
   PubMed Web of Science ®Google Scholar
• Singh N, Cohen PL. The T cell in sjogren’s syndrome: force majeure, not spectateur. J Autoimmun. 2012;39:229–233.
   PubMed Web of Science ®Google Scholar
• Katsifis GE, Moutsopoulos NM, Wahl SM. T lymphocytes in sjogren’s syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol. 2007;32:252–264.
   PubMed Web of Science ®Google Scholar
• Katsifis GE, Rekka S, Moutsopoulos NM, et al. Systemic and local interleukin-17 and linked cytokines associated with sjogren’s syndrome immunopathogenesis. Am J Pathol. 2009;175:1167–1177.
   PubMed Web of Science ®Google Scholar
• Nguyen CQ, Hu MH, Li Y, et al. Salivary gland tissue expression of interleukin-23 and interleukin-17 in sjogren’s syndrome: findings in humans and mice. Arthritis Rheum. 2008;58:734–743.
   PubMed Web of Science ®Google Scholar
• Alunno A, Bistoni O, Bartoloni E, et al. 17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary sjogren’s syndrome. Ann Rheum Dis. 2013;72:286–292.
   PubMed Web of Science ®Google Scholar
• Verstappen GM, Corneth OBJ, Bootsma H, et al. Th17 cells in primary sjogren’s syndrome: pathogenicity and plasticity. J Autoimmun. 2018;87:16–25.
   PubMed Web of Science ®Google Scholar
• Yan L, Hu F, Yan X, et al. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response. J Mol Med (Berl). 2016;94:1063–1079.
   PubMed Web of Science ®Google Scholar
• Bolandi Z, Mokhberian N, Eftekhary M, et al. Adipose derived mesenchymal stem cell exosomes loaded with miR-10a promote the differentiation of Th17 and Treg from naive CD4(+) T cell. Life Sci. 2020;259:118218.
   PubMed Web of Science ®Google Scholar
• Murugaiyan G, da Cunha AP, Ajay AK, et al. MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Invest. 2015;125:1069–1080.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xue Z, Liu Y, et al. MicroRNA-181c promotes Th17 cell differentiation and mediates experimental autoimmune encephalomyelitis. Brain Behav Immun. 2018;70:305–314.
   PubMed Web of Science ®Google Scholar
• Xiang HY, Pan F, Yan JZ, et al. [Upregulation of miR-498 suppresses Th17 cell differentiation by targeting STAT3 in rheumatoid arthritis patients]. Sheng Li Xue Bao. 2018;70:167–174.
   PubMedGoogle Scholar
• Husakova M. MicroRNAs in the key events of systemic lupus erythematosus pathogenesis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160:327–342.
   PubMed Web of Science ®Google Scholar
• Zheng CZ, Shu YB, Luo YL, et al. The role of miR-146a in modulating TRAF6-induced inflammation during lupus nephritis. Eur Rev Med Pharmacol Sci. 2017;21:1041–1048.
   PubMed Web of Science ®Google Scholar
• Kriegsmann M, Randau TM, Gravius S, et al. Expression of miR-146a, miR-155, and miR-223 in formalin-fixed paraffin-embedded synovial tissues of patients with rheumatoid arthritis and osteoarthritis. Virchows Arch. 2016;469:93–100.
   PubMed Web of Science ®Google Scholar
• Singh A, Patro PS, Aggarwal A. MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38:877–884.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Munoz A, Martinez-Hernandez R, Ramos-Levi AM, et al. Circulating microvesicles regulate Treg and Th17 differentiation in human autoimmune thyroid disorders. J Clin Endocrinol Metab. 2015;100:E1531–1539.
   PubMed Web of Science ®Google Scholar
• Martinez-Hernandez R, Sampedro-Nunez M, Serrano-Somavilla A, et al. Signature for evaluation of risk and severity of autoimmune thyroid diseases. J Clin Endocrinol Metab. 2018;103:1139–1150.
   PubMed Web of Science ®Google Scholar
• Wei H, Guan M, Qin Y, et al. Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves’ ophthalmopathy. Endocr J. 2014;61:1087–1092.
   PubMed Web of Science ®Google Scholar
• Wang N, Chen FE, Long ZW. Mechanism of MicroRNA-146a/Notch2 signaling regulating IL-6 in graves ophthalmopathy. Cell Physiol Biochem. 2017;41:1285–1297.
   PubMedGoogle Scholar
• Shi H, Zheng LY, Zhang P, et al. miR-146a and miR-155 expression in PBMCs from patients with sjogren’s syndrome. J Oral Pathol Med. 2014;43:792–797.
   PubMed Web of Science ®Google Scholar
• Wang-Renault SF, Boudaoud S, Nocturne G, et al. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary sjogren’s syndrome. Ann Rheum Dis. 2018;77:133–140.
   PubMed Web of Science ®Google Scholar
• Chen JQ, Papp G, Poliska S, et al. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjogren’s syndrome. PLoS One. 2017;12:e0174585.
   PubMed Web of Science ®Google Scholar
• Sun HY, Lv AK, Yao H. Relationship of miRNA-146a to primary sjogren’s syndrome and to systemic lupus erythematosus: a meta-analysis. Rheumatol Int. 2017;37:1311–1316.
   PubMed Web of Science ®Google Scholar
• Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715–725.
   PubMed Web of Science ®Google Scholar
• McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006;27:17–23.
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Chen Y, Tato CM, et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol. 2009;10:314–324.
   PubMed Web of Science ®Google Scholar
• Chen Z, Laurence A, Kanno Y, et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci U S A. 2006;103:8137–8142.
   PubMed Web of Science ®Google Scholar
• Wei L, Laurence A, Elias KM, et al. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem. 2007;282:34605–34610.
   PubMed Web of Science ®Google Scholar
• Murphy CA, Langrish CL, Chen Y, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198:1951–1957.
   PubMed Web of Science ®Google Scholar
• Awasthi A, Riol-Blanco L, Jager A, et al. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol. 2009;182:5904–5908.
   PubMed Web of Science ®Google Scholar
• Kopp T, Riedl E, Bangert C, et al. Clinical improvement in psoriasis with specific targeting of interleukin-23. Nature. 2015;521:222–226.
   PubMed Web of Science ®Google Scholar
• Zhang CJ, Wang C, Jiang M, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745.
   PubMed Web of Science ®Google Scholar
• Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385:729–733.
   PubMed Web of Science ®Google Scholar
• Franke M, Schroder J, Monhasery N, et al. Human and murine interleukin 23 receptors are novel substrates for a disintegrin and metalloproteases ADAM10 and ADAM17. J Biol Chem. 2016;291:10551–10561.
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Vanderkerken M, Hammad H. The emerging role of ADAM metalloproteinases in immunity. Nat Rev Immunol. 2018;18:745–758.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–558.
   PubMed Web of Science ®Google Scholar
• Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjogren’s syndrome: a data-driven, expert consensus approach in the sjogren’s international collaborative clinical alliance cohort. Arthritis Care Res (Hoboken). 2012;64:475–487.
   PubMed Web of Science ®Google Scholar
• Risso D, Massa MS, Chiogna M, et al. A modified LOESS normalization applied to microRNA arrays: a comparative evaluation. Bioinformatics. 2009;25:2685–2691.
   PubMed Web of Science ®Google Scholar
• DaFonseca S, Niessl J, Pouvreau S, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38.
   PubMed Web of Science ®Google Scholar
• Hundhausen C, Roth A, Whalen E, et al. Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression. Sci Transl Med. 2016;8:356ra119.
   PubMed Web of Science ®Google Scholar
• Lina C, Conghua W, Nan L, et al. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis. J Clin Immunol. 2011;31:596–605.
   PubMed Web of Science ®Google Scholar
• Chen H, Ma X, Liu Y, et al. Gut microbiota interventions with clostridium butyricum and norfloxacin modulate immune response in experimental autoimmune encephalomyelitis mice. Front Immunol. 2019;10:1662.
   PubMed Web of Science ®Google Scholar
• Luo A, Leach ST, Barres R, et al. The microbiota and epigenetic regulation of T helper 17/Regulatory T cells: in search of a balanced immune system. Front Immunol. 2017;8:417.
   PubMed Web of Science ®Google Scholar
• Miao M, Hao Z, Guo Y, et al. Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjogren’s syndrome. Ann Rheum Dis. 2018;77:1838–1840.
   PubMed Web of Science ®Google Scholar
• Afzali B, Lombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148:32–46.
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, O’Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006;441:231–234.
   PubMed Web of Science ®Google Scholar
• Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121–1133.
   PubMed Web of Science ®Google Scholar
• O’Shea JJ, Steward-Tharp SM, Laurence A, et al. Signal transduction and Th17 cell differentiation. Microbes Infect. 2009;11:599–611.
   PubMed Web of Science ®Google Scholar
• Miralles M, Eixarch H, Tejero M, et al. Clinical and histopathological amelioration of experimental autoimmune encephalomyelitis by AAV vectors expressing a soluble Interleukin-23 receptor. Neurotherapeutics. 2017;14:1095–1106.
   PubMed Web of Science ®Google Scholar
• Yu RY, Gallagher G. A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells. J Immunol. 2010;185:7302–7308.
   PubMed Web of Science ®Google Scholar
• Kan SH, Mancini G, Gallagher G. Identification and characterization of multiple splice forms of the human interleukin-23 receptor alpha chain in mitogen-activated leukocytes. Genes Immun. 2008;9:631–639.
   PubMed Web of Science ®Google Scholar